Company Overview
| Stock Name | Guanze Medical |
|---|---|
| Stock Code | 02427 |
| Company Full Name | To be extracted |
| Industry | 醫療保健 |
| Principal Activities | 主要在中國提供醫用影像膠片產品及醫學影像云服務。 |
| Listing Date | 2022-12-29 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國山東省濟南市高新區春暉路2966號濟南高新區戰略性新興產業基地10座501-A室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://www.guanzegroup.com/ |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 0.53 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 29.2% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 10,221,050 |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
Pool A
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 5,000 | HK$ 2,650 |
| 2 lots | 10,000 | HK$ 5,300 |
| 3 lots | 15,000 | HK$ 7,950 |
| 4 lots | 20,000 | HK$ 10,600 |
| 5 lots | 25,000 | HK$ 13,250 |
| 6 lots | 30,000 | HK$ 15,900 |
| 7 lots | 35,000 | HK$ 18,550 |
| 8 lots | 40,000 | HK$ 21,200 |
| 9 lots | 45,000 | HK$ 23,850 |
| 10 lots | 50,000 | HK$ 26,500 |
| 12 lots | 60,000 | HK$ 31,800 |
| 14 lots | 70,000 | HK$ 37,100 |
| 16 lots | 80,000 | HK$ 42,400 |
| 18 lots | 90,000 | HK$ 47,700 |
| 20 lots | 100,000 | HK$ 53,000 |
| 30 lots | 150,000 | HK$ 79,500 |
| 40 lots | 200,000 | HK$ 106,000 |
| 50 lots | 250,000 | HK$ 132,500 |
| 60 lots | 300,000 | HK$ 159,000 |
| 70 lots | 350,000 | HK$ 185,500 |
| 80 lots | 400,000 | HK$ 212,000 |
| 90 lots | 450,000 | HK$ 238,500 |
| 100 lots | 500,000 | HK$ 265,000 |
| 120 lots | 600,000 | HK$ 318,000 |
| 140 lots | 700,000 | HK$ 371,000 |
| 160 lots | 800,000 | HK$ 424,000 |
| 180 lots | 900,000 | HK$ 477,000 |
| 200 lots | 1,000,000 | HK$ 530,000 |
| 300 lots | 1,500,000 | HK$ 795,000 |
| 400 lots | 2,000,000 | HK$ 1,060,000 |
| 700 lots | 3,500,000 | HK$ 1,855,000 |
| 800 lots | 4,000,000 | HK$ 2,120,000 |
| 1,400 lots | 7,000,000 | HK$ 3,710,000 |
| 1,600 lots | 8,000,000 | HK$ 4,240,000 |
Stock Connect Inclusion
| HK Market Cap | --- |
|---|
| 26Q2 Regular Review | |
| Inclusion Pathway | None |
|---|---|
| Est. Threshold | --- |
| Analysis Result | 无法确定入通路径 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 1.75 |
|---|---|
| First Day Open | HK$ 1.2 |
| First Day Change | 230.19% |
| First Day Volume | 63010000.0 |
| First Day Turnover | 92718800.0 |
Use of Proceeds
| Use of Proceeds | 1、約34.0百萬港元（約46.4%）將用于延伸至山東省東部，以擴闊客戶基礎及進一步鞏固于山東省的市場地位； 2、約27.4百萬港元（約37.3%）將用于藉由策略性收購、取得醫療器械注冊證及將軟硬件升級以加強醫學影像云服務的供應； 3、約2.0百萬港元（約2.7%）將用于擴大產品組合以橫向擴充價值鏈； 4、約1.8百萬港元（約2.5%）將用于藉由參與交易會、貿易展覽及會議，不斷推廣我們的品牌及增加市場知名度； 5、約1.8百萬港元（約2.5%）將用于我們的信息科技系統升級； 6、約6.3百萬港元（約8.6%）將用作額外營運資金及其他一般企業用途。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
Southwest Securities (HK) Capital Limited CE AIC042
Overall Coordinators (3)
Joint Bookrunners (10)
SOUTHWEST SECURITIES (HK) BROKERAGE LIMITED CE ACB501
GOLDLINK SECURITIES LIMITED CE BHH779
Funde Securities Limited CE BHT984
BOCOM International Securities Limited CE APJ121
ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299
SHENWAN HONGYUAN SECURITIES (H.K.) LIMITED CE AAC927
SPDB International Capital Limited CE BFZ375
ZHONGTAI INTERNATIONAL SECURITIES LIMITED CE BAA855
Alpha Financial Group Limited CE ALW542
Apricot Capital (Hong Kong) Limited CE ACX624
Joint Lead Managers (11)
SOUTHWEST SECURITIES (HK) BROKERAGE LIMITED CE ACB501
GOLDLINK SECURITIES LIMITED CE BHH779
Funde Securities Limited CE BHT984
BOCOM International Securities Limited CE APJ121
ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299
SHENWAN HONGYUAN SECURITIES (H.K.) LIMITED CE AAC927
SPDB International Capital Limited CE BFZ375
ZHONGTAI INTERNATIONAL SECURITIES LIMITED CE BAA855
Alpha Financial Group Limited CE ALW542
Apricot Capital (Hong Kong) Limited CE ACX624
I WIN SECURITIES LIMITED CE BJB315
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Carsonlin Investment Ltd | 22,111,600 HKD | — | 21.60% | — | 6 months | 2023-06-29 |
| 2 | 慕敏 | 2,210,100 HKD | — | 2.20% | — | 6 months | 2023-06-29 |
| 3 | 杨新云 | 5,527,900 HKD | — | 5.40% | — | 6 months | 2023-06-29 |
Directors & Management
| Chairman | 孟憲震 |
|---|---|
| Company Secretary | 鄭章勁 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Meng A Capital Limited(74.96%) |
|---|
